Date and time
12:00 PM - 1:00 PM PT
How are technological advances impacting the selection of patients for clinical trials? What's the impact of immunotherapy on cancer treatment? And how is response-to-therapy currently monitored?
Our current understanding of the basic biology of cancer disease is assisting physicians in stratifying patients for select therapies. Join us and learn more.
Steve Silverstein, M.B.A.
Chair Emeritus, Board of Directors
Melanoma Research Foundation